Crescent Biopharma (CBIO) Capital Expenditures (2013 - 2026)
Crescent Biopharma (CBIO) reported Capital Expenditures of $13,000 for Q2 2026, down 90.7% from $140,000 a year earlier and down 91.2% from the prior quarter.
Powered by 
Analysis
Crescent Biopharma (CBIO) Capital Expenditures (2013 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Crescent Biopharma's Capital Expenditures came in at $939,000, up 570.7% year-over-year; for FY2025, it came in at $919,000.
- Capital Expenditures has a five-year compound annual growth rate of 68.1% (FY2020 to FY2025).
- By year, Capital Expenditures came in at $9,972 in FY2024 (-53.4%), $21,394 in FY2023 (-74.6%), $84,191 in FY2022 (+463.4%) and $14,943 in FY2021 (-78.2%).
- The Q2 2026 figure ranks as the lowest quarterly Capital Expenditures since Q2 2024.
- The high point for year-over-year Capital Expenditures in five years was Q2 2022 (growth of 707.3%); the low point was Q4 2022 (a decline of 100.0%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $147,000 (Q1 2026), $193,000 (Q4 2025) and $586,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 1.32 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 322.00 Mn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 893.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | -321.00 Mn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -763.00 Mn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 513.00 Mn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 140.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 533.00 Mn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 112.20 Mn |
| 10 | Crescent Biopharma | 403.30 Mn | -304.00 Mn | - | 13,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 13,000.00 |
| Mar 31, 2026 | 147,000.00 |
| Dec 31, 2025 | 193,000.00 |
| Sep 30, 2025 | 586,000.00 |
| Jun 30, 2025 | 140,000.00 |
| Jun 30, 2024 | 2,533.00 |
| Mar 31, 2024 | 7,439.00 |
| Dec 31, 2023 | 801.00 |
| Sep 30, 2023 | 7,866.00 |
| Jun 30, 2023 | 10,530.00 |
| Mar 31, 2023 | 2,197.00 |
| Dec 31, 2022 | 1.00 |
| Sep 30, 2022 | 2,483.00 |
| Jun 30, 2022 | 41,186.00 |
| Mar 31, 2022 | 40,521.00 |
| Dec 31, 2021 | 2,447.00 |
| Sep 30, 2021 | 4,334.00 |
| Jun 30, 2021 | 5,102.00 |
| Mar 31, 2021 | 3,060.00 |
| Dec 31, 2020 | 38,175.00 |
API Access
Crescent Biopharma Capital Expenditures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-expenditures&ticker=CBIO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-expenditures", "ticker": "CBIO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=capital-expenditures&ticker=CBIO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();